Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Other Accumulated Expenses (2024 - 2025)

Mangoceuticals (MGRX) has disclosed Other Accumulated Expenses for 2 consecutive years, with $20056.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 94.62% to $20056.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20056.0 through Dec 2025, down 94.62% year-over-year, with the annual reading at $20056.0 for FY2025, 94.62% down from the prior year.
  • Other Accumulated Expenses hit $20056.0 in Q4 2025 for Mangoceuticals, down from $160684.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $400000.0 in Q2 2024 to a low of $20056.0 in Q4 2025.